Welcome Cure
PrivateLast Round
Early Funding
Oct 19, 2023
Total Funding Raised
$6.5M
Company Overview
Welcome Cure operates in Healthcare & Life Sciences and is based in Mumbai. Its latest recorded funding round was an Early Funding round in October 2023.
Welcome Cure is a healthtech company that provides an AI-powered integrative healthcare platform offering telemedicine, digital diagnostics, and traditional medical consultations.
Sector
Healthcare & Life Sciences
Verticals
Telemedicine, Medical AI, Patient Engagement, Vertical SaaS, Healthcare Analytics
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting, Usage-Based SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Welcome Cure Comparables
Compare Welcome Cure with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Pristyn Care | 78% | |
| DocOnline | 77% | |
| MediBuddy | 73% |
For institutional investors. Book with your work email.
Welcome Cure Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Oct 19, 2023 | ||||
| Angel | Jul 20, 2018 | ||||
| Seed | Oct 7, 2015 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Welcome Cure Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Inflection Point Ventures | Early Funding |
| Brand Capital | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 12, 2026
Monthly visitors grew 72% MoM, reaching 32.8K.
- Jan 21, 2026
Monthly visitors increased 47% MoM.
For institutional investors. Book with your work email.
Welcome Cure Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Welcome Cure's valuation, stock price, and market status.
Is Welcome Cure a public or private company?
Welcome Cure is a private company.
What is the current stock price of Welcome Cure?
Welcome Cure is a private company, so its shares have no public market price. Caplight tracks Welcome Cure's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Welcome Cure worth (valuation)?
Valuation information for Welcome Cure is not publicly available.
Can I buy Welcome Cure stock?
Welcome Cure shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Welcome Cure's last funding round?
Welcome Cure's most recent funding round was Early Funding on October 19, 2023.
Who are the main investors in Welcome Cure?
Key investors in Welcome Cure include Inflection Point Ventures, Brand Capital.
Will Welcome Cure IPO soon?
No public IPO plans have been announced for Welcome Cure.
How can I track Welcome Cure secondary market activity?
Caplight tracks bids, offers, and trades in Welcome Cure's shares on secondary markets.